Since joint nutrient deprivation and mTOR inhibition appear to synergistically impair cellular growth, we propose that chemical or dietary amino acid/nutrient restriction could be explored as a potential adjuvant strategy to enhance the therapeutic efficacy of rapamycin in FA− deficient HNSCCs, an approach supported by the promise of dietary interventions in other cancer contexts [75,76]. Here, MTOR is linked to cancer.